相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice
Volker Neuschmelting et al.
THERANOSTICS (2018)
Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors
Matthew J. O'Shaughnessy et al.
CLINICAL CANCER RESEARCH (2018)
Theranostic Liposomes with HypoxiaActivated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy
Liangzhu Feng et al.
ACS NANO (2017)
Chemophototherapy: An Emerging Treatment Option for Solid Tumors
Dandan Luo et al.
ADVANCED SCIENCE (2017)
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer
Weigang Yan et al.
LANCET ONCOLOGY (2017)
Targeting Phosphatidylinositol 3-Kinase Signaling Pathway for Therapeutic Enhancement of Vascular-Targeted Photodynamic Therapy
Daniel Kraus et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT)
Juanjuan Dang et al.
BIOMATERIALS SCIENCE (2017)
Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer
Rui Zhang et al.
BIOMATERIALS (2017)
Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy
Kwanghee Kim et al.
CLINICAL CANCER RESEARCH (2017)
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
Jia-nan Liu et al.
CHEMICAL REVIEWS (2017)
Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy
Yazhe Wang et al.
ACS NANO (2017)
Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models
James P. B. O'Connor et al.
CANCER RESEARCH (2016)
Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy
Kai Yang et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies
Bora Jang et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy
Chenggen Qian et al.
ADVANCED MATERIALS (2016)
Tumor priming using metronomic chemotherapy with neovasculature-targeted, nanoparticulate paclitaxel
Xin Luan et al.
BIOMATERIALS (2016)
Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells
Rong Sun et al.
BIOMATERIALS (2016)
Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery
Cong-Fei Xu et al.
BIOMATERIALS (2016)
Enhancement of cell adhesion, retention, and survival of HUVEC/cbMSC aggregates that are transplanted in ischemic tissues by concurrent delivery of an antioxidant for therapeutic angiogenesis
Chieh-Cheng Huang et al.
BIOMATERIALS (2016)
Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
Francis W. Hunter et al.
BRITISH JOURNAL OF CANCER (2016)
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
Roger M. Phillips
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Antiangiogenic therapy in oncology: current status and future directions
Gordon C. Jayson et al.
LANCET (2016)
A photoactivable multi-inhibitor nanoliposome for tumour control and simultaneous inhibition of treatment escape pathways
Bryan Q. Spring et al.
NATURE NANOTECHNOLOGY (2016)
Sphingomyelin Liposomes Containing Porphyrin-phospholipid for Irinotecan Chemophototherapy
Kevin A. Carter et al.
THERANOSTICS (2016)
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
Haojun Chen et al.
THERANOSTICS (2016)
Multifunctional Polymeric Nanosystems for Dual-Targeted Combinatorial Chemo/Angiogenesis Therapy of Tumors
Fatima Zohra Dahmani et al.
ADVANCED HEALTHCARE MATERIALS (2016)
Hypoxia Induced by Upconversion-Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors
Yanyan Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy
Ya-Rong Liu et al.
BIOMATERIALS (2015)
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Ulrich Laechelt et al.
CHEMICAL REVIEWS (2015)
H2O2-Activatable and O2-Evolving Nanoparticles for Highly Efficient and Selective Photodynamic Therapy against Hypoxic Tumor Cells
Huachao Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Multifunctional ultrasmall nanoplatforms for vascular-targeted interstitial photodynamic therapy of brain tumors guided by real-time MRI
Denise Bechet et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy
Yuhao Cheng et al.
NATURE COMMUNICATIONS (2015)
Spherical Cancer Models in Tumor Biology
Louis-Bastien Weiswald et al.
NEOPLASIA (2015)
Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles
Zipeng Zhen et al.
ACS NANO (2014)
MSN-Mediated Sequential Vascular-to-Cell Nuclear-Targeted Drug Delivery for Efficient Tumor Regression
Limin Pan et al.
ADVANCED MATERIALS (2014)
Hypoxia- Targeted siRNA Delivery
F. Perche et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
M. T. Huggett et al.
BRITISH JOURNAL OF CANCER (2014)
The role of strong hypoxia in tumors after treatment in the outcome of bacteriochlorin-based photodynamic therapy
Martyna Krzykawska-Serda et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization
Andrea Weiss et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles
Yang Liu et al.
JOURNAL OF CONTROLLED RELEASE (2014)
PEGylation of magnetic poly(glycidyl methacrylate) microparticles for microfluidic bioassays
Jana Kucerova et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2014)
The use of nanoparticulate delivery systems in metronomic chemotherapy
De-Hong Yu et al.
BIOMATERIALS (2013)
Polyethylene Glycol and Polyethylenimine Dual-Functionalized Nano-Graphene Oxide for Photothermally Enhanced Gene Delivery
Liangzhu Feng et al.
SMALL (2013)
Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion
Patrycja Nowak-Sliwinska et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
The in vivo behavior and antitumor activity of doxorubicin-loaded poly(γ-benzyl L-glutamate)-block-hyaluronan polymersomes in Ehrlich ascites tumor-bearing BalB/c mice
Kamal Kumar Upadhyay et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
Hyukjin Lee et al.
NATURE NANOTECHNOLOGY (2012)
Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
Annamaria Rapisarda et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Multifunctional Peptide-Conjugated Hybrid Silica Nanoparticles for Photodynamic Therapy and MRI
Hamanou Benachour et al.
THERANOSTICS (2012)
A new 18F-labeled BBN-RGD peptide heterodimer with a symmetric linker for prostate cancer imaging
Yongjun Yan et al.
AMINO ACIDS (2011)
Photodynamic Therapy of Cancer: An Update
Patrizia Agostinis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
The effect and clinical consequences of hypoxia on cytochrome P450, membrane carrier proteins activity and expression
Patrick du Souich et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Assessment and Monitoring Tumor Vascularity With Contrast-Enhanced Ultrasound Maximum Intensity Persistence Imaging
Marybeth A. Pysz et al.
INVESTIGATIVE RADIOLOGY (2011)
Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP)
Dina Preise et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer Drugs
Liming Zhang et al.
SMALL (2010)
The Hypoxia-Activated ProDrug AQ4N Penetrates Deeply in Tumor Tissues and Complements the Limited Distribution of Mitoxantrone
Oliver Tredan et al.
CANCER RESEARCH (2009)
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
Clustering and Internalization of Integrin αvβ3 With a Tetrameric RGD-synthetic Peptide
Lucie Sancey et al.
MOLECULAR THERAPY (2009)
Understanding biophysicochemical interactions at the nano-bio interface
Andre E. Nel et al.
NATURE MATERIALS (2009)
Generation of singlet oxygen via the composites of water-soluble thiol-capped CdTe quantum dots - Sulfonated aluminum phthalocyanines
Jiong Ma et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2008)
PEGylated nanographene oxide for delivery of water-insoluble cancer drugs
Zhuang Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging
Weibo Cai et al.
NATURE PROTOCOLS (2008)
Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Irene Noguera-Troise et al.
NATURE (2006)
Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N
A. Yakkundi et al.
CANCER GENE THERAPY (2006)
Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine:: A substudy of Trans-Tasman Radiation Oncology Group study 98.02
D Rischin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A cytochrome P4502B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4N
V McErlane et al.
JOURNAL OF GENE MEDICINE (2005)
Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels
K Ichikawa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
Effect of hypoxia on cytochrome P450 activity and expression
C Fradette et al.
CURRENT DRUG METABOLISM (2004)
Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations
F Ungaro et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2003)
Bioreductively activated antitumor N-oxides: The case of AQ4N, a unique approach to hypoxia-activated cancer chemotherapy
LH Patterson
DRUG METABOLISM REVIEWS (2002)
分享论文
